#genomics

RevereAsset's profile picture

📺💡Could Genomics Be The Next Big AI Theme? $ARKG $NTRA $GH $TWST Please ❤️like, 🔖bookmark, and 🔁share with fellow growth stock traders/investors In this Short Insight video, Ted Zhang explores why #genomics could become the next major AI investment theme, highlighting the technical breakout in $ARKG and the growing role of artificial intelligence in scientific discovery. * Artificial intelligence has spent the past few years transforming infrastructure—driving massive rallies in chips, networking, memory, cooling, and hyperscalers. But what happens after the infrastructure is built? The next major opportunity may lie in AI's application layer, with genomics emerging as one of the strongest long-term themes. Why? * Let's look at ARK Genomic Revolution ETF $ARKG, which has quietly undergone a remarkable technical transformation. After soaring during the COVID era, the ETF collapsed roughly 85% from peak to trough before finding what appears to be a durable bottom in early 2025. Since then, it has spent nearly four years building a large Stage 1 base—a type of long-term consolidation that often precedes new secular uptrends. * One of the most important signals was the failed breakdown and reclaim in early 2025, suggesting institutional buyers stepped in aggressively after weak hands were shaken out. Now, #ARKG has pushed above its anchored VWAP from the 2021 peak, meaning the average investor who bought near the highs is finally back in profit for the first time in years. Combined with price trading above all major moving averages—8, 21, 50, 150, and 200-day—all of which are rising, the technical picture has improved dramatically. * The fundamental story may be even more compelling. Biology generates enormous amounts of complex data, making genomics one of the most natural use cases for AI. Large language models and AI agents can analyze DNA, proteins, medical research, and statistical datasets far more efficiently than humans, accelerating scientific discovery and uncovering patterns that may otherwise go unnoticed. As AI models mature, genomics could become one of the technology's most impactful real-world applications. * Ted also highlights several leading holdings within ARKG. Natera $NTRA, one of Stanley Druckenmiller's largest reported positions, recently broke out to new all-time highs following strong earnings. Guardant Health $GH, a leader in liquid biopsy technology, is approaching its 2021 highs, where a breakout would leave virtually no overhead resistance. Twist Bioscience $TWST also recovered impressively after an earnings-related gap down, producing a bullish engulfing reversal at its 50-day moving average before advancing to new 52-week highs. * The combination of improving technicals, institutional accumulation, and AI-driven fundamental tailwinds suggests genomics may be in the early innings of a new long-term bull market. While AI infrastructure has led this cycle so far, genomics could become one of the next major themes as artificial intelligence expands from building models to transforming scientific research and medicine. * Learn how Revere Asset Management can help you manage your capital ▶️ More information about Revere Asset Management is in the FAQ section on our website, along with additional insights into our investment process, portfolio structure, and onboarding.

Revere Asset Management

15,484 просмотров • 1 месяц назад